HF006
The percentage of patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction, who are currently treated with a beta-blocker licensed for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2020 | 1557 | 1723 | 90.4% | |
| HF006 | 2021 | 2003 | 2245 | 89.2% | |
| HF006 | 2022 | 2265 | 2364 | 95.8% | |
| HF006 | 2023 | 2599 | 2675 | 97.2% |
